Literature DB >> 24995401

Primary prevention of preterm birth.

Joachim W Dudenhausen.   

Abstract

Mesh:

Year:  2014        PMID: 24995401     DOI: 10.1515/jpm-2014-0036

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


× No keyword cloud information.
  5 in total

1.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

2.  A transcervical amniotic fluid collector: a new medical device for the assessment of amniotic fluid in patients with ruptured membranes.

Authors:  Seung Mi Lee; Roberto Romero; Joong Shin Park; Piya Chaemsaithong; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2015-07       Impact factor: 1.901

3.  An elevated amniotic fluid prostaglandin F2α concentration is associated with intra-amniotic inflammation/infection, and clinical and histologic chorioamnionitis, as well as impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Jee Yoon Park; Roberto Romero; JoonHo Lee; Piya Chaemsaithong; Noppadol Chaiyasit; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-12-15

4.  Controversies about the Secondary Prevention of Spontaneous Preterm Birth.

Authors:  Ioannis Kyvernitakis; Holger Maul; Franz Bahlmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-06-25       Impact factor: 2.915

5.  Challenges in Acceptance and Compliance in Digital Health Assessments During Pregnancy: Prospective Cohort Study.

Authors:  Katharina Brusniak; Hannah Maria Arndt; Manuel Feisst; Kathrin Haßdenteufel; Lina Maria Matthies; Thomas Maximilian Deutsch; Hannes Hudalla; Harald Abele; Markus Wallwiener; Stephanie Wallwiener
Journal:  JMIR Mhealth Uhealth       Date:  2020-10-14       Impact factor: 4.773

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.